Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 18, 2010, Pages 8340-8345

  Changa, Jihoon ^a   Voorheesa, Timothy J ^a   Liub, Yusen ^b   Zhaoc, Yongge ^c   Changa, Cheong Hee ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cytokine; NF B; TLR

Indexed keywords

I KAPPA B KINASE BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 23P19; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TH1 CELL; TH17 CELL;

ANIMALS; CELLS, CULTURED; DENDRITIC CELLS; DOWN-REGULATION; DUAL SPECIFICITY PHOSPHATASE 1; I-KAPPA B KINASE; INTERLEUKIN-12; INTERLEUKIN-23 SUBUNIT P19; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PHOSPHATASE 2; RNA, SMALL INTERFERING;

EID: 77952392957     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0914703107     Document Type: Article

References (33)

1. Kastelein RA, Hunter CA, Cua DJ (2007) Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 25: 221-242.
2. Oppmann B, et al. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13: 715-725.
3. Hunter CA (2005) New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 5:521-531.
4. Smits HH, et al. (2004) Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 34:1371-1380.
5. Sheibanie AF, Tadmori I, Jing H, Vassiliou E, Ganea D (2004) Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J 18:1318-1320. (Pubitemid 39561589)
6. Khayrullina T, Yen JH, Jing H, Ganea D (2008) In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells. J Immunol 181:721-735.
7. Gerosa F, et al. (2008) Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells. J Exp Med 205:1447-1461. (Pubitemid 351831499)
8. Kawai T, Akira S (2007) Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med 13:460-469.
9. Häcker H, Karin M (2006) Regulation and function of IKK and IKK-related kinases. Sci STKE 2006:re13.
10. Gerondakis S, et al. (2006) Unravelling the complexities of the NF-kappaB signalling pathway using mouse knockout and transgenic models. Oncogene 25:6781-6799. (Pubitemid 44657852)
11. Hayden MS, Ghosh S (2008) Shared principles in NF-kappaB signaling. Cell 132: 344-362.
12. Courtois G (2008) Tumor suppressor CYLD: Negative regulation of NF-kappaB signaling and more. Cell Mol Life Sci 65:1123-1132.
13. Kovalenko A, et al. (2003) The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424:801-805. (Pubitemid 37021712)
14. Cohen P (1989) The structure and regulation of protein phosphatases. Annu Rev Biochem 58:453-508.
15. Kray AE, et al. (2005) Positive regulation of IkappaB kinase signaling by protein serine/threonine phosphatase 2A. J Biol Chem 280:35974-35982. (Pubitemid 41633866)
16. Li S, Wang L, Berman MA, Zhang Y, Dorf ME (2006) RNAi screen in mouse astrocytes identifies phosphatases that regulate NF-kappaB signaling. Mol Cell 24:497-509. (Pubitemid 350284222)
17. Götz J, Probst A, Ehler E, Hemmings B, Kues W (1998) Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci USA 95:12370-12375. (Pubitemid 28483772)
18. Chang J, Kunkel SL, Chang CH (2009) Negative regulation of MyD88-dependent signaling by IL-10 in dendritic cells. Proc Natl Acad Sci USA 106:18327-18332.
19. Zhao Q, et al. (2006) MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203:131-140. (Pubitemid 43139652)
20. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M (1997) A cytokineresponsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388:548-554. (Pubitemid 27339997)
21. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179-189. (Pubitemid 43214587)
22. Sheppeck JE, 2nd, Gauss CM, Chamberlin AR (1997) Inhibition of the Ser-Thr phosphatases PP1 and PP2A by naturally occurring toxins. Bioorg Med Chem 5: 1739-1750.
23. Bialojan C, Takai A (1988) Inhibitory effect of a marine-sponge toxin, okadaic acid, on protein phosphatases. Specificity and kinetics. Biochem J 256:283-290.
24. Prajapati S, Verma U, Yamamoto Y, Kwak YT, Gaynor RB (2004) Protein phosphatase 2Cbeta association with the IkappaB kinase complex is involved in regulating NF-kappaB activity. J Biol Chem 279:1739-1746. (Pubitemid 38084441)
25. Kuwata H, et al. (2006) IkappaBNS inhibits induction of a subset of Toll-like receptordependent genes and limits inflammation. Immunity 24:41-51. (Pubitemid 43077199)
26. Min W, et al. (2008) AIP1 recruits phosphatase PP2A to ASK1 in tumor necrosis factorinduced ASK1-JNK activation. Circ Res 102:840-848. (Pubitemid 351521590)
27. Longin S, et al. (2004) An inactive protein phosphatase 2A population is associated with methylesterase and can be re-activated by the phosphotyrosyl phosphatase activator. Biochem J 380:111-119. (Pubitemid 38725735)
28. Kikly K, Liu L, Na S, Sedgwick JD (2006) The IL-23/Th(17) axis: Therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18:670-675. (Pubitemid 44635178)
29. Lee E, et al. (2004) Increased expression of interleukin 23 p19 and p40 in lesional skin of patients with psoriasis vulgaris. J Exp Med 199:125-130. (Pubitemid 38076484)
30. Schmidt C, et al. (2005) Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: Elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis. Inflamm Bowel Dis 11:16-23. (Pubitemid 40340252)
31. Vaknin-Dembinsky A, Balashov K, Weiner HL (2006) IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production. J Immunol 176:7768-7774. (Pubitemid 43849078)
32. Zhang J, et al. (2006) Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J Clin Invest 116:3042-3049. (Pubitemid 44684489)
33. Yao Y, Li W, Kaplan MH, Chang CH (2005) Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells. J Exp Med 201:1899-1903. (Pubitemid 41002926)